Dynamic Treatment Regimes, STAR*D & Voting D. Lizotte, E. Laber & S. Murphy ENAR March 2009.

Slides:



Advertisements
Similar presentations
Piloting and Sizing Sequential Multiple Assignment Randomized Trials in Dynamic Treatment Regime Development 2012 Atlantic Causal Inference Conference.
Advertisements

CmpE 104 SOFTWARE STATISTICAL TOOLS & METHODS MEASURING & ESTIMATING SOFTWARE SIZE AND RESOURCE & SCHEDULE ESTIMATING.
Treatment Effect Heterogeneity & Dynamic Treatment Regime Development S.A. Murphy.
11 Confidence Intervals, Q-Learning and Dynamic Treatment Regimes S.A. Murphy Time for Causality – Bristol April, 2012 TexPoint fonts used in EMF. Read.
Inference for Clinical Decision Making Policies D. Lizotte, L. Gunter, S. Murphy INFORMS October 2008.
Using Clinical Trial Data to Construct Policies for Guiding Clinical Decision Making S. Murphy & J. Pineau American Control Conference Special Session.
Experimenting to Improve Clinical Practice S.A. Murphy AAAS, 02/15/13 TexPoint fonts used in EMF. Read the TexPoint manual before you delete this box.:
1 Dynamic Treatment Regimes Advances and Open Problems S.A. Murphy ICSPRAR-2008.
The Simple Linear Regression Model: Specification and Estimation
Linear Methods for Regression Dept. Computer Science & Engineering, Shanghai Jiao Tong University.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan JSM: August, 2005.
Dynamic Treatment Regimes, STAR*D & Voting D. Lizotte, E. Laber & S. Murphy LSU ---- Geaux Tigers! April 2009.
Substance Abuse, Multi-Stage Decisions, Generalization Error How are they connected?! S.A. Murphy Univ. of Michigan CMU, Nov., 2004.
An Experimental Paradigm for Developing Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan March, 2004.
Constructing Dynamic Treatment Regimes & STAR*D S.A. Murphy ICSA June 2008.
Screening Experiments for Developing Dynamic Treatment Regimes S.A. Murphy At ICSPRAR January, 2008.
Point estimation, interval estimation
SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have CPDD June, 2005.
Dynamic Treatment Regimes: Challenges in Data Analysis S.A. Murphy Survey Research Center January, 2009.
Q-Learning and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan IMS/Bernoulli: July, 2004.
1 A Prediction Interval for the Misclassification Rate E.B. Laber & S.A. Murphy.
Sizing a Trial for the Development of Adaptive Treatment Strategies Alena I. Oetting The Society for Clinical Trials, 29th Annual Meeting St. Louis, MO.
Screening Experiments for Dynamic Treatment Regimes S.A. Murphy At ENAR March, 2008.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan Florida: January, 2006.
Hypothesis Testing and Dynamic Treatment Regimes S.A. Murphy Schering-Plough Workshop May 2007 TexPoint fonts used in EMF. Read the TexPoint manual before.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan UNC: November, 2003.
1 A Confidence Interval for the Misclassification Rate S.A. Murphy & E.B. Laber.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan PSU, October, 2005 In Honor of Clifford C. Clogg.
Planning Survival Analysis Studies of Dynamic Treatment Regimes Z. Li & S.A. Murphy UNC October, 2009.
Statistical Issues in Developing Adaptive Treatment Strategies for Chronic Disorders S.A. Murphy Univ. of Michigan CDC/ATSDR: March, 2005.
Hypothesis Testing and Dynamic Treatment Regimes S.A. Murphy, L. Gunter & B. Chakraborty ENAR March 2007.
A Finite Sample Upper Bound on the Generalization Error for Q-Learning S.A. Murphy Univ. of Michigan CALD: February, 2005.
Dynamic Treatment Regimes, STAR*D & Voting D. Lizotte, E. Laber & S. Murphy Psychiatric Biostatistics Symposium May 2009.
An Experimental Paradigm for Developing Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan February, 2004.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan Yale: November, 2005.
Methods for Estimating the Decision Rules in Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan IBC/ASC: July, 2004.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan April, 2006.
SMART Designs for Developing Dynamic Treatment Regimes S.A. Murphy MD Anderson December 2006.
Exploratory Analyses Aimed at Generating Proposals for Individualizing and Adapting Treatment S.A. Murphy BPRU, Hopkins September 22, 2009.
SMART Experimental Designs for Developing Adaptive Treatment Strategies S.A. Murphy ISCTM, 2007.
1 A Prediction Interval for the Misclassification Rate E.B. Laber & S.A. Murphy.
Experiments and Adaptive Treatment Strategies S.A. Murphy Univ. of Michigan Chicago: May, 2005.
Susan Murphy, PI University of Michigan Acknowledgements: MCAT network and NIH The Goal To facilitate methodological collaborations necessary for producing.
Experiments and Dynamic Treatment Regimes S.A. Murphy At NIAID, BRB December, 2007.
1 Machine/Reinforcement Learning in Clinical Research S.A. Murphy May 19, 2008.
Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Strategies Convergence, 2008.
Experiments and Dynamic Treatment Regimes S.A. Murphy Univ. of Michigan January, 2006.
Revisiting an Old Topic: Probability of Replication D. Lizotte, E. Laber & S. Murphy Johns Hopkins Biostatistics September 23, 2009.
1 Variable Selection for Tailoring Treatment S.A. Murphy, L. Gunter & J. Zhu May 29, 2008.
Hypothesis Testing and Adaptive Treatment Strategies S.A. Murphy SCT May 2007.
Adaptive Treatment Strategies: Challenges in Data Analysis S.A. Murphy NY State Psychiatric Institute February, 2009.
Sequential, Multiple Assignment, Randomized Trials and Treatment Policies S.A. Murphy UAlberta, 09/28/12 TexPoint fonts used in EMF. Read the TexPoint.
Overview of Adaptive Treatment Regimes Sachiko Miyahara Dr. Abdus Wahed.
Estimating parameters in a statistical model Likelihood and Maximum likelihood estimation Bayesian point estimates Maximum a posteriori point.
Sequential, Multiple Assignment, Randomized Trials and Treatment Policies S.A. Murphy MUCMD, 08/10/12 TexPoint fonts used in EMF. Read the TexPoint manual.
Biostatistics Case Studies 2007 Peter D. Christenson Biostatistician Session 3: Incomplete Data in Longitudinal Studies.
Analysis of Variance (ANOVA) Can compare the effects of different treatments Can make population level inferences based on sample population.
Chapter 5 Parameter estimation. What is sample inference? Distinguish between managerial & financial accounting. Understand how managers can use accounting.
통계적 추론 (Statistical Inference) 삼성생명과학연구소 통계지원팀 김선우 1.
The Simple Linear Regression Model: Specification and Estimation ECON 4550 Econometrics Memorial University of Newfoundland Adapted from Vera Tabakova’s.
Descriptive Statistics Used to describe a data set –Mean, minimum, maximum Usually include information on data variability (error) –Standard deviation.
Simulation Study for Longitudinal Data with Nonignorable Missing Data Rong Liu, PhD Candidate Dr. Ramakrishnan, Advisor Department of Biostatistics Virginia.
Machine Learning 5. Parametric Methods.
SMART Trials for Developing Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Designs NCDEU, 2006.
Copyright (c) 2004 Brooks/Cole, a division of Thomson Learning, Inc. Chapter 7 Inferences Concerning Means.
Bias-Variance Analysis in Regression  True function is y = f(x) +  where  is normally distributed with zero mean and standard deviation .  Given a.
Sample Size Determination
Multiple Imputation using SOLAS for Missing Data Analysis
Where did we stop? The Bayes decision rule guarantees an optimal classification… … But it requires the knowledge of P(ci|x) (or p(x|ci) and P(ci)) We.
Clinical prediction models
Presentation transcript:

Dynamic Treatment Regimes, STAR*D & Voting D. Lizotte, E. Laber & S. Murphy ENAR March 2009

2 Dynamic treatment regimes are individually tailored treatments, with treatment type and dosage changing according to patient outcomes. Operationalize clinical practice. k Stages for one individual Observation available at j th stage Action at j th stage (usually a treatment)

3 Goal : Construct decision rules that input information available at each stage and output a recommended decision; these decision rules should lead to a maximal mean Y. Y is a known function of The dynamic treatment regime is the sequence of two decision rules: k=2 Stages

4 Optimal Dynamic Treatment Regime satisfies

5 Data for Constructing the Dynamic Treatment Regime: Subject data from sequential, multiple assignment, randomized trials. At each stage subjects are randomized among alternative options. A j is a randomized treatment with known randomization probability.

6 STAR*D

7 STAR*D Analyses X 1 includes site, preference for future treatment and can include other baseline variables. X 2 can include measures of symptoms (Qids), side effects, preference for future treatment Y is (reverse-coded) the minimum of the time to remission and 30 weeks.

8 Regression-based methods for constructing decision rules Q-Learning (Watkins, 1989) (a popular method from computer science) Optimal nested structural mean model (Murphy, 2003; Robins, 2004) The first method is equivalent to an inefficient version of the second method, when using linear models, each stages’ covariates include the prior stages’ covariates and the actions are centered to have conditional mean zero.

9 There is a regression for each stage. A Simple Version of Q-Learning – Stage 2 regression: Regress Y on to obtain Stage 1 regression: Regress on to obtain

10 for patients entering stage 2: is the average outcome conditional on patient history (no remission in stage 1; includes past treatment and variables affected by stage 1 treatment). is the estimated average outcome assuming the “best” treatment is provided at stage 2 (note max in formula). is the dependent variable in the stage 1 regression for patients moving to stage 2

11 A Simple Version of Q-Learning – Stage 2 regression, (using Y as dependent variable) yields Stage 1 regression, (using as dependent variable) yields

12 Decision Rules:

13 Measures of Confidence Classical –Confidence/Credible intervals and/or p- values concerning the β 1, β 2. –Confidence/Credible intervals concerning the average response if is used in future to select the treatments.

14 A Measure of Confidence for use in Exploratory Data Analysis Voting –Estimate the chance that a future trial would find a particular stage j treatment best for a given s j. The vote for treatment a j * is

15 A Measure of Confidence for use in Exploratory Data Analysis Voting –If stage j treatment a j is binary, coded in {-1,1}, then

16 The Vote: Intuition If has a normal distribution with variance matrix then is

17 Bootstrap Voting An inconsistent bootstrap vote estimator of is

18 Bootstrap Voting A consistent bootstrap vote estimator of is where is smooth and

19 What does the vote mean? is similar to 1- pvalue for the hypothesis in that it converges, as n increases, to 1 or 0 depending on the sign of If then the limiting distribution is not uniform; instead converges to a constant.

20 STAR*D Regression formula at stage 2:

21

22 STAR*D Regression formula at stage 1:

23 STAR*D Decision Rule for subjects preferring a switch at stage 1 if offer VEN if offer SER if offer BUP

24 STAR*D Level 2, Switch

25

26

27 Truth in Advertising: STAR*D Missing Data + Study Drop-Out 1200 subjects begin level 2 (e.g. stage 1) 42% study dropout during level 2 62% study dropout by 30 weeks. Approximately 13% item missingness for important variables observed after the start of the study but prior to dropout.

28 Truth in Advertising: STAR*D Multiple Imputation within Bootstrap 1000 bootstrap samples of the 1200 subjects Using the location-scale model we formed 25 imputations per bootstrap sample. The stage j Q-function (regression function) for a bootstrap sample is the average of the 25 Q-functions over the 25 imputations.

29 Discussion We consider the use of voting to provide a measure of confidence in exploratory data analyses. Our method of adapting the bootstrap voting requires a tuning parameter. It is unclear how to best select this tuning parameter. We ignored the bias in estimators of stage 1 parameters due to the fact that these parameters are non-regular. The voting method should be combined with bias reduction methods.

30 This seminar can be found at: seminars/ENAR2009.ppt me with questions or if you would like a copy!